EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies

Hsing-Yu Lin, Shu-Chen Hu, Tsung-Yu Pai, Fang-Ju Lin iD, Chien-Chih Wu iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s557802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Hsing-Yu Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Antifungal Agents, Triazoles, Mycoses. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsAntifungal AgentsTriazolesMycosesHumansMaleFemaleMiddle AgedRisk FactorsCase-Control StudiesTaiwanAdultAgedDrug Monitoring

Stichwörter der Autor:innen

antifungal prophylaxishematologic malignanciesposaconazoletherapeutic drug monitoring

Substanzen

posaconazoleAntifungal AgentsTriazoles

Autor:innen und Institutionen

  • Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
  • School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.

ORCID-Profile: Fang-Ju Lin, Chien-Chih Wu

Zitieren

APA

Lin, H. Y., Hu, S. C., Pai, T. Y., Lin, F. J., & Wu, C. C. (2025). Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s557802

Vancouver

Lin HY, Hu SC, Pai TY, Lin FJ, Wu CC. Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s557802

BibTeX
@article{Lin2025,
  author = {Lin, Hsing-Yu and Hu, Shu-Chen and Pai, Tsung-Yu and Lin, Fang-Ju and Wu, Chien-Chih},
  title = {Plasma Concentrations of Prophylactic Posaconazole and Risk Factors for Subtherapeutic Exposure in Taiwanese Patients with Hematologic Malignancies},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s557802}
}
Kostenlos starten →